XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets    
Cash $ 638,311
Prepaid expenses 55,741
Total Current Assets 694,052
Deferred offering costs 200,034
Demand deposit in Trust Account 61,648,194
Total Assets 62,342,246 200,034
Current Liabilities    
Accounts payable and accrued expenses 106,250 2,416
Total Current Liabilities 106,250 252,128
Total Liabilities 106,250 252,128
Commitments and Contingencies (Note 6)
Ordinary shares subject to possible redemption, $0.0001 par value, 490,000,000 shares authorized, 6,000,000 and 0 shares issued and outstanding, respectively 61,648,194
Shareholders’ Equity (Deficit)    
Preference shares, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding
Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 1,944,290 shares and 1,500,000 issued and outstanding (excluding 6,000,000 shares and 0 shares subject to possible redemption) as of September 30, 2025 and December 31, 2024, respectively [1] 194 150
Additional paid-in capital 24,850
Retained earnings (Accumulated deficit) 587,608 (77,094)
Total Shareholders’ Equity (Deficit) 587,802 (52,094)
Total Liabilities, Shares Subject to Possible Redemption, and Shareholders’ Equity (Deficit) 62,342,246 200,034
Related Party    
Current Liabilities    
Promissory note – related party $ 249,712
[1] Ordinary shares have been retroactively restated to reflect the Sponsor’s forfeiture of 225,000 Founder Shares on March 10, 2025 for no consideration as the underwriters of the IPO did not exercise the over-allotment option.